Wavefront-guided Photorefractive Keratectomy (PRK) Versus Wavefront-guided Lasik for Myopia

NCT ID: NCT01140594

Last Updated: 2022-04-11

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 34 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2006-08-31
• Study Completion Date: 2008-01-31

Brief Summary

A prospective comparison of eyes undergoing wavefront-guided LASIK in one eye and wavefront-guided PRK in their fellow eye for myopia.

Detailed Description

This is a research study comparing the outcomes of LASIK surgery to PRK surgery for nearsightedness when using the two different procedures. You will have one eye treated with LASIK using the Intralase FS laser and your other eye treated with PRK. You will be one of 100 sighted patients at Stanford to undergo treatment in this clinical research trial. This will be a prospective, randomized, research study in which up to 200 consecutive eyes scheduled to undergo excimer laser in situ keratomileusis (LASIK) in one eye and photorefractive keratectomy (PRK) in the fellow eye for the correction of myopia (nearsightedness) with or without astigmatism will be enrolled. The choice of which eye receives LASIK and which eye receives PRK will be randomized prior to enrollment. Randomization will be done according to a randomization schedule. You will know which eye is being treated with which procedure. The randomization will determine only whether your right or left eye is treated with the LASIK procedure. The other eye will be treated with PRK. You have a fifty percent chance of having your left eye treated with LASIK as your right eye. Subjects will undergo either bilateral (both eyes at once) wavefront (a more precise custom laser system) guided LASIK and PRK treatments using the VISX Star S4 excimer laser. All subjects will be followed for one year after the vision correction procedure. Subjects scheduled to undergo LASIK and PRK for the correction of myopia (nearsightedness) with or without astigmatism will be screened for eligibility. Eligible subjects will be examined preoperatively to establish a baseline for ocular condition (the general health and glasses prescription of the eyes). Postoperatively, subjects will undergo an ophthalmic evaluation (complete eye examination) at regular intervals as specified in this protocol. Retreatments (a second operation on the same eye for residual nearsightedness) will not be allowed during the first six months of this study. If you elect to undergo a retreatment of your LASIK or PRK surgery prior to the 6-month post-operative visit, the retreated eye will be exited from the study as of the retreatment date.

Any significant new finding developed during the course of the research which may relate to the subject's willingness to continue participation will be provided to the subject or subject's representative in a timely manner.

Conditions

Myopia; Astigmatism

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: OTHER
• Blinding Strategy: NONE

Study Groups

Wavefront-guided PRK

Wavefront-guided PRK

Group Type: ACTIVE_COMPARATOR

Photorefractive keratectomy

Intervention Type: PROCEDURE

One eye undergoes wavefront-guided PRK with the Visx S4 CustomVue excimer laser.

Laser in-situ keratomileusis

Intervention Type: PROCEDURE

One eye undergoes wavefront-guided LASIK using the Visx S4 excimer laser.

Wavefront-guided LASIK

Wavefront-guided LASIK

Group Type: ACTIVE_COMPARATOR

Photorefractive keratectomy

Intervention Type: PROCEDURE

One eye undergoes wavefront-guided PRK with the Visx S4 CustomVue excimer laser.

Laser in-situ keratomileusis

Intervention Type: PROCEDURE

One eye undergoes wavefront-guided LASIK using the Visx S4 excimer laser.

Interventions

Photorefractive keratectomy

One eye undergoes wavefront-guided PRK with the Visx S4 CustomVue excimer laser.

Intervention Type: PROCEDURE

Laser in-situ keratomileusis

One eye undergoes wavefront-guided LASIK using the Visx S4 excimer laser.

Intervention Type: PROCEDURE

Other Intervention Names

PRK, CustomVue, Wavefront-guided; LASIK, CustomVue, Visx, Intralase FS60

Eligibility Criteria

Inclusion Criteria

• Subjects age 21 and older with healthy eyes.
• Nearsightedness between -0.75 diopters and -7.00 diopters with or without astigmatism of up to -3.50 diopters.

Exclusion Criteria

• Subjects under the age of 21.
• Patients with thin corneas.
• Patients with topographic irregularities.
• Patients with keratoconus.
• Patients with autoimmune diseases.
• Patients who are pregnant or nursing.
• Patients must have similar levels of nearsightedness in each eye. They can not be more than 1.0 diopter of difference between eyes.
• Patients must have similar levels of astigmatism in each eye. They can not have more than 1.0 diopter of difference between eyes.

• Minimum Eligible Age: 21 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Stanford University

OTHER

Sponsor Role: lead

Responsible Party

Edward E. Manche

Professor of Ophthalmology

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Edward E. Manche

Role: PRINCIPAL_INVESTIGATOR

Stanford University

Locations

Stanford University School of Medicine

Stanford, California, United States

Countries

United States

References

Manche EE, Haw WW. Wavefront-guided laser in situ keratomileusis (Lasik) versus wavefront-guided photorefractive keratectomy (Prk): a prospective randomized eye-to-eye comparison (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2011 Dec;109:201-20.

Reference Type: RESULT

PMID: 22253488 (View on PubMed)

Other Identifiers

SQL 97234

Identifier Type: -

Identifier Source: secondary_id

SU-05192010-6082

Identifier Type: -

Identifier Source: org_study_id